Smith & Nephew (LSE:SN.) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


LSE:SN. Smith & Nephew PLC LSE:SN.
86 GF Score
Price £11.53
GF Value £11.87
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Smith & Nephew Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Smith & Nephew's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

LSE:SN. vs ABT, SYK, MDT: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Devices subindustry, Smith & Nephew's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Smith & Nephew Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Smith & Nephew's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Smith & Nephew's Margin of Safety % (DCF Earnings Based) falls into.


LSE:SN.
86GF Score
Smith & Nephew PLC LSE:SN.
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Smith & Nephew (LSE:SN.) Overvalued in 2026?

Based on GuruFocus' analysis, Smith & Nephew stock appears to be undervalued. The current stock price of £11.53 is trading 2.9% below its estimated GF Value™ of £11.87. GuruFocus considers Smith & Nephew to be Fairly Valued.

Key valuation signals for LSE:SN.:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: £11.87 vs. price of £11.53 (2.9% below fair value)
  • GF Score™: 86/100 with 3 warning signs

No single metric tells the full story. See the LSE:SN. stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Smith & Nephew Business Description

Address Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
86GF Score

Get the complete analysis for LSE:SN.

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£11.53
Price
£11.87
GF Value